Clinical Trial Update: A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

View source ↗

Summary

This is a screening study by TScan Therapeutics to collect samples for tumor-associated antigens, HLA typing, and HLA loss of heterozygosity in patients with me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Head and Neck Cancer
• Hpv16-related Cancers
• Non-small Cell Lung Cancer
• Nut Carcinoma
• Sarcoma
• Uveal Melanoma

Snippet

Sponsor: TScan Therapeutics, Inc. | Conditions: Head and Neck Cancer, Cervical Cancer | Status: ACTIVE_NOT_RECRUITING